BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17448616)

  • 1. Immuno-targeting of nonionic surfactant vesicles to inflammation.
    Hood E; Gonzalez M; Plaas A; Strom J; VanAuker M
    Int J Pharm; 2007 Jul; 339(1-2):222-30. PubMed ID: 17448616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
    Yeom S; Shin BS; Han S
    Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entrapment enhancement of peptide drugs in niosomes.
    Manosroi A; Khanrin P; Werner RG; Götz F; Manosroi W; Manosroi J
    J Microencapsul; 2010 May; 27(3):272-80. PubMed ID: 20113169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound enhancement of drug release across non ionic surfactant vesicle membranes.
    Hood E; Gonzalez M; Strom J; VanAuker M
    Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3527-30. PubMed ID: 17271051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing.
    Lo CT; Jahn A; Locascio LE; Vreeland WN
    Langmuir; 2010 Jun; 26(11):8559-66. PubMed ID: 20146467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
    Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
    Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
    Gupta M; Vaidya B; Mishra N; Vyas SP
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A; Jantrawut P; Manosroi J
    Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.
    El-Ridy MS; Abdelbary A; Essam T; El-Salam RM; Kassem AA
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1491-508. PubMed ID: 21707323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niosomes as carriers of radiopaque contrast agents for X-ray imaging.
    Muller D; Foulon M; Bonnemain B; Vandamme TF
    J Microencapsul; 2000; 17(2):227-43. PubMed ID: 10738698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence and dynamic light scattering studies of niosomes-membrane mimetic systems.
    Girigoswami A; Das S; De S
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Jul; 64(4):859-66. PubMed ID: 16330244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
    Kamboj S; Saini V; Bala S
    ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
    Abdelkader H; Ismail S; Kamal A; Alany RG
    Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.
    Yang DB; Zhu JB; Huang ZJ; Ren HX; Zheng ZJ
    Colloids Surf B Biointerfaces; 2008 Jun; 63(2):192-9. PubMed ID: 18295461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP; Vyas SP
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A; Varshosaz J; Rouholamini A
    Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.